$150 saving All shipments to UAE, Middle East and Africa! Special offer ends for 2026 January. Email transports@cryomedicalogistics.com
Worldwide Leader in Secure and Reliable Dedicated Cryo Shipping and IVF Courier Services
led by Biomedical Scientists.
15+
Years of Experience
100%
Success Rate
2750+
Handy Carry Transports
80+
Countries Delivered
Your Trusted Partner in Secure, Safe, and Reliable Cryogenic Transport
Cryogenic Material Transport
Cryo Medical Logistics, a division of Greenplace Healthcare—an ISO 9001:2015 certified company—specializes in the secure and efficient hand-carry and cargo transport of cryogenic reproductive and pharmaceutical materials. Our expert team ensures the integrity and viability of these critical biological samples are maintained throughout every stage of the logistics process.
Clinical Trial and Stem Cell Logistics
We provide specialized logistics for clinical trials, offering secure, time-critical transport of biological samples and investigational products worldwide. Our services include temperature-controlled solutions using dry ice and liquid nitrogen (LN2) for frozen and cryogenic shipments. With real-time tracking, regulatory support, and strict chain-of-custody protocols, we ensure sample integrity from collection to delivery. Trusted by CROs, labs, and pharma partners, we deliver precision and reliability at every stage.
Specialised Logistics Software and Insurance
Utilizing specialized cutting-edge software with live map tracking and real-time temperature monitoring technology, we ensure optimal conditions throughout the cryogenic transport of biological materials, safeguarding their preservation and quality at every stage.
Compliance
At Cryo Medical Logistics, we are committed to providing the highest level of service and maintaining compliance with all relevant industry regulations and standards. We follow the guidelines set forth by leading organizations to ensure the safe, secure, and efficient transport of biological materials, including cryogenic shipments.
Federal Ministry of
Health Nigeria
HFEA UK
EU Tissue and Cells Directive (2004/23/EC)
U.S. Food and Drug Administration
